KPNA3 was found overexpressed in the sorafenib-resistant PDX models and was further confirmed to induce EMT and sorafenib resistance of HCC cells through KPNA3-AKT-ERK-TWIST signalling. Here, EPHB2 is linked to hepatocellular carcinoma.